Target intelligence / Profile preview

Variable charge X-linked protein 1 (VCX1)

Target
VCX1
Molecular classification
Nuclear protein, Chromatin-binding protein, Cancer/Testis antigen
01

Overview

Variable charge X-linked protein 1 (VCX1) is a member of the VCX/Y gene family, which encodes small, highly charged nuclear proteins primarily expressed in male germ cells. Located on the X chromosome at p22.31, the VCX gene cluster is characterized by significant copy number polymorphism among individuals and plays a critical role in spermatogenesis and neuronal development. VCX1 is involved in fundamental cellular processes including chromatin organization, ribosome assembly, and the regulation of mRNA stability, specifically by inhibiting mRNA decapping. Clinically, deletions in the Xp22.3 region encompassing the VCX genes are associated with X-linked ichthyosis and have been implicated in non-specific mental retardation. Due to its restricted expression in the testis and aberrant expression in various malignancies such as lung cancer, VCX1 is classified as a Cancer/Testis (CT) antigen, making it a potential candidate for targeted cancer immunotherapies and vaccine development.

Other names
VCXVCX-10rVCX-B1VCX10RVCXB1Variable charge protein on X with ten repeatsVariable charge X-linked
02

Mechanism of action

Regulation of mRNA stability through inhibition of decapping and modulation of ribosome assembly during germ cell development.

03

Biological functions

SpermatogenesisBrain developmentRibosome assemblyChromatin organizationmRNA decapping regulationCell proliferationApoptosis regulation
04

Disease associations

X-linked ichthyosisKallmann syndromeMale infertilityLung cancerMental retardationChronic hepatitis B
05

Safety considerations

Potential for off-target effects on spermatogenesis and male fertilityPotential neurodevelopmental risks due to expression in the brainHigh sequence identity among VCX family members may lead to lack of specificity
06

Biomarkers

VCX protein expression in testisVCX mRNA expression in lung adenocarcinomaVCX gene copy number variationVCX DNA methylation status

Beyond the preview

Go deeper on Variable charge X-linked protein 1 (VCX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Variable charge X-linked protein 1 (VCX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call